The Latest Breaking News from Small Pharma

Ayahuasca psychedelic DMT shows promise as depression therapy

Study finds participants saw reduction in depressive symptoms as researchers welcome ‘promising’ results

The Guardian - US · Feb 25

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds

Dimethyltryptamine is a powerful hallucinogenic found in several plants and can be smoked, snorted or mixed with ayahuasca

The Independent UK · Apr 4, 2023

Psychedelic drug improves symptoms of depression for six months – study

Dimethyltryptamine is a powerful hallucinogenic found in several plants and can be smoked, snorted or mixed with ayahuasca.

The Independent UK · Apr 4, 2023

Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know

Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras.

Benzinga · Jul 19, 2022

DMT Therapy Developer Small Pharma Posts Financial Results, Reaffirms Potential Of Short-Acting Psychedelics

Biotech company Small Pharma Inc. (OTCQB: DMTTF), producer of short-acting psychedelic-assisted therapies for diverse mental health conditions, announced its financial results earlier this month for the fiscal year ended Feb. 28, 2022.

Benzinga · Jun 23, 2022

A Deeper Look At DMT Trials & Studies

This article by Elisabetta Fato was originally published on Microdose and appears here with permission.

Benzinga · Jun 14, 2022

Cybin, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68

Benzinga · May 23, 2022

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Benzinga · May 6, 2022

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Benzinga · May 2, 2022

Psychedelic Stock Gainers And Losers From April 20, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:

Benzinga · Apr 20, 2022